Infection control during gastrointestinal endoscopy

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 3, 2003, Pages 159-167

  Nelson, Douglas B ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; CLEANING; COLONOSCOPY; DISEASE TRANSMISSION; DISINFECTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE PERSONNEL; HUMAN; INFECTION; INFECTION CONTROL; MICROFLORA; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SCLEROTHERAPY; SIGMOIDOSCOPY;

EID: 0037338981     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2003.24     Document Type: Review

References (85)

1. Botoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc 1986;32:342-6.
2. Raines DR, Branche WC, Anderson DL, Boyce HW Jr. The occurrence of bacteremia after esophageal dilation. Gastrointest Endosc 1975;22:86-7.
3. Stephenson PM, Dorrington L, Harris OD, Rao A. Bacteraemia following oesophageal dilatation and oesophago-gastroscopy. Aust N Z J Med 1977;7:32-5.
4. Golladay ES, Tepas JJ III, Pickard LR, Seibert JJ, Brown RW, Haller JA Jr. Bacteremia after esophageal dilation: a clinical and experimental study. Ann Thorac Surg 1979;30:19-23.
5. Yin TP, Dellipiani AW. Bacterial endocarditis after Hurst bougienage in a patient with a benign oesophageal stricture. Endoscopy 1983;15:27-8.
6. Welsh JD, Griffiths WJ, McKee J, Wilkinson D, Flournoy DJ, Mohr JA. Bacteremia associated with esophageal dilatation. J Clin Gastroenterol 1983;5:109-12.
7. Nelson DB, Sanderson SJ, Azar MM. Bacteremia with esophageal dilation. Gastrointest Endosc 1998;48:563-7.
8. Zuccaro G Jr, Richter JE, Rice TW, Achkar E, Easley K, Lewis J, et al. Viridans streptococcal bacteremia after esophageal stricture dilation. Gastrointest Endosc 1998;48:568-73.
9. Hirota WK, Wortman GW, Maydonovitch CL, Chang AS, Midkiff RB, Wong RKH, et al. The effect of oral decontamination with clindamycin palmitate on the prospective incidence of bacteremia after esophageal dilation: a prospective trial. Gastrointest Endosc 1999;50:475-9.
10. Camara DS, Gruber M, Barde CJ, Montes M, Caruana JA Jr, Chung R. Transient bacteremia following endoscopic injection sclerotherapy of esophageal varices. Arch Intern Med 1983;143:1350-2.
11. Cohen LB, Korsten MA, Scherl EJ, Velez ME, Fisse RD, Arons E. Bacteremia after endoscopic injection sclerosis. Gastrointest Endosc 1983;29:198-200.
12. Gerhartz HH, Sauerbruch T, Weinzierl M, Ruckdeschel G. Nosocomial speticemia in patients undergoing sclerotherapy for variceal hemorrhage. Endoscopy 1984;16:129-30.
13. Brayko C, Kozarek R, Sanowski R, Testa A. Bacteremia during esophageal variceal scleotherapy: its cause and prevention. Gastrointest Endosc 1985;31:10-2.
14. Sauerbruch T, Holl J, Ruckdeschel G, Förstl J, Weinzierl M. Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy 1985;17:170-2.
15. Shady H, Korsten MA, Waye JD. The relationship of bacteremia to the length of the injection needle in endoscopic variceal sclerotherapy. Gastrointest Endosc 1985;31:243-6.
16. Low DE, Shoenut JP, Kennedy JK, Harding GKM, Den Boer B, Micflikier AB. Infectious complications of endoscopic injection sclerotherapy. Arch Intern Med 1986;146:569-71.
17. Hegnhøj J, Andersen JR, Jarløv JO, Bendtsen F, Rasmussen HS. Bacteriaemia after injection sclerotherapy of oesophageal varices. Liver 1988;8:167-71.
18. Lorgat F, Madden MV, Kew G, Roditi D, Krige JEJ, Bornman PC, et al. Bacteremia after injection of esophageal varices. Surg Endosc 1990;4:18-9.
19. Ho H, Zuckerman MJ, Wassem C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterology 1991;101:1642-8.
20. Lo G-H, Lai K-H, Shen M-T, Chang C-F. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 1994;40:675-9.
21. Selby WS, Norton ID, Pokorny CS, Benn RAV. Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 1994;40:680-4.
22. da Silveira MR, Siqueira ES, Brant CQ, Morais M, Libera ED Jr, Castro RR, et al. Prospective study of bacteremia rate after elastic band ligation and sclerotherapy of esophageal varices in patients with hepatosplenic schistosomiasis. Gastrointest Endosc 1997;46:321-3.
23. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 1995;123:280-7.
24. Tseng C-C, Green RM, Burke SK, Connors PJ, Carr-Locke DL. Bacteremia after endoscopic band ligation of esophageal varices. Gastrointest Endosc 1992;38:336-7.
25. Lin OS, Wu S-S, Chen Y-Y, Soon M-S. Bacterial peritonitis after elective endoscopic variceal ligation: a prospective study. Am J Gastroenterol 2000;95:214-7.
26. Meyer GW. Prophylaxis of infective endocarditis during gastrointestinal procedures: report of a survey. Gastrointest Endosc 1979;25:1-2.
27. Rumfeld W, Wallace G, Scott BB. Bacterial endocarditis after endoscopy. Lancet 1980;2:1083.
28. Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AGW, Young SEJ. The bowel, the genitourinary tract, and infective endocarditis. Br Heart J 1984;51:339-45.
29. Niv Y, Bat L, Motro M. Bacterial endocarditis after Hurst bougienage in a patient with a benign esophageal stricture and mitral valve prolapse. Gastrointest Endosc 1985;31:265-7.
30. Breuer GS, Yinnon AM, Halevy J. Infective endocarditis associated with upper endoscopy: case report and review. J Infect 1998;36:342-4.
31. Logan RF, Hastings JGM. Bacterial endocarditis: a complication of gastroscopy. Br Med J 1988;296:1107.
32. Baskin G. Prosthetic endocarditis after endoscopic variceal sclerotherapy: a failure of antibiotic prophylaxis. Am J Gastroenterol 1989;84:311-2.
33. Pritchard TM, Foust RT, Cantey JR, Leman RB. Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after gastrointestinal endoscopy. Am J Med 1991;90:516-8.
34. Montalto M, La Regina M, Gemelli P, Manna R, Gasbarrini G. Mitral valve endocarditis caused by Streptococcus oralis occurring after upper gastrointestinal endoscopy. Am J Gastroenterol 2002;97:2149-50.
35. Goldman GD, Miller SA, Furman DS, Brock D, Ryan JL, McCallum RW. Does bacteremia occur during flexible sigmoidoscopy? Am J Gastroenterol 1985;80:621-3.
36. Llach J, Elizalde I, Bordas JM, Ginés A, Almela M, Sans M, et al. Prospective assessment of the risk of bacteremia in cirrhotic patients undergoing lower gastrointestinal endoscopy. Gastrointest Endosc 1999;49:214-7.
37. Low DE, Shoenut JP, Kennedy JK, Sharma GP, Harding GKM, Den Boer B, et al. Prospective assessment of risk of bacteremia with colonoscopy and polypectomy. Dig Dis Sci 1987;32:1239-43.
38. Shorvon PJ, Eykyn SJ, Cotton PB. Gastrointestinal instrumentation, bacteraemia, and endocarditis. Gut 1983;24:1078-93.
39. Murray JL. Enterococcal endocarditis after sigmoidoscopy. West J Med 1984;141:689-90.
40. Rodriguez W, Levine JS. Enterococcal endocarditis following flexible sigmoidoscopy. West J Med 1984;140:951-3.
41. Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1985;80:438-41.
42. Jain NK, Larson DE, Schroeder KW, Burton DD, Cannon KP, Thompson RL, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. Ann Intern Med 1987;107:824-9.
43. Akkersdijk WL, van Bergeijk JD, van Egmond T, Mulder CJJ, van Berge Henegouwen GP, van der Werken C, et al. Percutaneous endoscopic gastrostomy (PEG): comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995;27:313-6.
44. Sturgis TM, Yancy W, Cole JC, Proctor DD, Minhas BS, Marcuard SP. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1996;91:2301-4.
45. Preclik G, Grüne S, Leser HG, Lebherz J, Heldwein W, Machka K, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999;319:881-4.
46. Dormann AJ, Wigginghaus B, Risius H, Kleimann F, Kloppenborg A, Grünewald T, et al. A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications. Am J Gastroenterol 1999;94:3220-4.
47. Gossner L, Keymling J, Hahn EG, Ell C. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy 1999;31:119-24.
48. Panigrahi H, Shreeve DR, Tan WC, Prudham R, Kaufman R. Role of antibiotic prophylaxis for wound infection in percutaneous endoscopic gastrostomy (PEG): result of a prospective double-blind randomized trial. J Hosp Infect 2002;50:312-5.
49. Sharma VK, Howden C. Meta-analysis of randomized controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000;95:3133-6.
50. Earnshaw JJ, Clark AW, Thom BT. Outbreak of Pseudomonas aeruginosa following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1985;6:95-7.
51. Allen JI, Allen MOC, Olson MM, Gerding DN, Shanholtzer CJ, Meier PB, et al. Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope. Gastroenterology 1987;92:759-63.
52. Streulens MJ, Rost F, Deplano A, Maas A, Schwam V, Serruys E, et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med 1993;95:489-98.
53. Barawi M, Gottlieb K, Cunha B, Portis M, Gress F. A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration. Gastrointest Endosc 2001;53:189-92.
54. Dajani A, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
55. American Society for Gastrointestinal Endoscopy (ASGE). Antibiotic prophylaxis for gastrointestinal endoscopy. Gastrointest Endosc 1995;42:630-5.
56. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-28.
57. Modlin IM. A brief history of endoscopy. Milan: Multimed, 2000.
58. Axon ATR, Phillips I, Cotton PB, Avery SA. Disinfection of gastrointestinal fibre endoscopes. Lancet 1974;1:656-8.
59. Axon ATR, Banks J, Cockel R, Deverill CEA, Newman C. Disinfection in upper-digestive-tract endoscopy in Britain. Lancet 1981;1:1093-4.
60. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-42.
61. American Society for Gastrointestinal Endoscopy (ASGE). Infection control during gastrointestinal endoscopy: guidelines for clinical application. Gastrointest Endosc 1988;34:37S-40S.
62. Anonymous. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a working party of the British Society of Gastroenterology. Gut 1988;29:1134-51.
63. Kimmey MB, Burnett DA, Carr-Locke DL, DiMarino AJ, Jensen DM, Katon R, et al. Transmission of infection by gastrointestinal endoscopy. Gastrointest Endosc 1993;36:885-8.
64. Waye JD, Alvarez SZ, Kothari K, Novis B, Xiao S-D, Rainoldi JL, et al. Disinfection of endoscopic equipment. Gastrointest Endosc 1999;49:668-70.
65. Tandon R, Ahuja V. Non-United States guidelines for endoscope reprocessing. Gastroenterol Clin North Am 2000;10:295-318.
66. Lo Passo C, Pernice I, Celeste A, Perdichizzi G, Todaro-Luck F. Transmission of Trichosporon asahii esophagitis by a contaminated endoscope. Mycoses 2001;44:13-21.
67. Bronowicki J-P, Venard V, Botté C, Monhoven N, Gastin I, Choné L, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337:237-40.
68. Tennenbaum R, Colardelle P, Chochon M, Maisonneuve P, Jean F, Andrieu J. Hépatite C après cholangiographie rétrograde. Gastroenterol Clin Biol 1993;17:763-75.
69. Le Pogam S, Gondeau A, Bacq Y. Nosocomial transmission of hepatitis C virus. Ann Intern Med 1999;131:794.
70. Davis AR, Pink JM, Kowalik AM, Wylie BR, McCaughan GW. Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust 1996;164:571.
71. Federman DG, Kirsner RS. Leukocytoclastic vasculitis, hepatitis B, and the risk of endoscopy. Cutis 1999;63:86-7.
72. WHO infection control guidelines for transmissible spongiform encephalopathies. Geneva: WHO/CDS/CSR/APH/2000.3, 1999.
73. Alvarado CJ, Mark R. APIC guidelines for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-55.
74. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin infect Dis 2001;32:1348-56.
75. Petrosillo N, Puro V, Jagger J, Ippolito G. The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting. Am J Infect Control 1995;23:278-85.
76. Garner JS, Hierholzer WJ, McCormick RD, Adams AB, Craven DE, Fleming DW, et al. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80.
77. Mohandas KM, Gopalakrishnan G. Mucocutaneous exposure to body fluids during digestive endoscopy: the need for universal precautions. Indian J Gastroenterol 1999;18:109-11.
78. Gorse GJ, Messner RL. Infection control practices in gastrointestinal endoscopy in the United States: a national survey. Infect Control Hosp Epidemiol 1991;12:289-96.
79. Mitchell HM, Lee A, Carrick J. Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol 1989;24:396-400.
80. Chong J, Marshall BJ, Barkin JS, McCallum RW, Reiner DK, Hoffman SR, et al. Occupational exposure to Helicobacter pylori for the endoscopy professional: a sera epidemiological study. Am J Gastroenterol 1994;89:1987-92.
81. Liu WZ, Xiao D, Jiang R-R, Pang ZJ. Seroprevalence of Helicobacter pylori infection in medical staff in Shanghai. Scand J Gastroenterol 1996;31:749-52.
82. Su Y-C, Wang W-M, Chen L-T, Chiang W, Chen C-Y, Lu S-N, et al. High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan. Dig Dis Sci 1996;41:1571-6.
83. Nishikawa J, Kawai H, Takahashi A, Seki T, Yoshikawa N, Akita Y, et al. Seroprevalence of immunoglobulin G antibodies against Helicobacter pylori among endoscopy personnel in Japan. Gastrointest Endosc 1998;48:237-43.
84. Braden B, Duan L-P, Caspary WF, Lembcke B. Endoscopy is not a risk factor for Helicobacter pylori infection - but medical practice is. Gastrointest Endosc 1997;46:305-10.
85. Rudi J, Töppe H, Marx N, Zuna I, Theilmann L, Stremmel W, et al. Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol 1996;92:258-62.